Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF | V.TLT.W

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by GRAMPS1996on Oct 11, 2017 8:39am

93 Views

Post# 26798178

RE:RE:Asian licensing??

vestor111 wrote: I have suggested regional licensing for a small company makes a lot of sense. I am not sure if Frost's uro-oncology interests run too deep in Europe, Asia or ROW (Rest of World) so it might make sense for him to negotiate for an NA license and possibly suggest partners in other markets given his years of knowledge and contacts.

Pure speculation but regional licensing is a logical option with licensing fees (in part or in full at signing) with sales and royalty payments throughout the licensing period. Such a deal could be announced without notice and infuse significant cash into the company virtually over night.

The license could include many other facets that strengthen the value of the license and the relationship.

If Frost puts an oar in these waters, the pharma world will take notice.

The Buffett of Biotech's Portfolio - Forbes

https://www.forbes.com/.../01/03/the-buffett-of-biotechs-portfolio

2017-01-03 · The Buffett of Biotech's Portfolio . ... Through Opko Health, billionaire Dr. Phillip Frost ... marketer of new drugs in Eastern Europe. Opko owns a 17% ...